Dimerix Completes Part Two of Recruitment for Phase 3 Kidney Disease Trial

MT NewswiresDec 30, 2024 19:45 ET

Dimerix Says Kidney Disease Trial to Continue After Independent Review; Shares Down 3%

MT NewswiresNov 20, 2024 22:14 ET

Companies Like Dimerix (ASX:DXB) Can Afford To Invest In Growth

Yahoo FinanceNov 20, 2024 18:35 ET

Dimerix Ltd: Dimerix Receives $7.9M R&D Tax Incentive Rebate

ASXNov 14, 2024 16:54 ET · Announcements

Dimerix Partners With UK's Rare Kidney Disease Registry for Recruitment for ACTION3 Phase Three Clinical Trial

MT NewswiresSep 15, 2024 23:23 ET

Euroz Hartleys Adjusts Dimerix's Price Target to AU$0.91 From AU$0.86; Keeps at Speculative Buy

MT NewswiresSep 13, 2024 04:12 ET · Ratings